No profile data available.
Pluri Inc. (PLUR) is a healthcare company in the drug manufacturing contractors industry, based in Haifa, Israel, with about 92 full-time employees.
It reported revenue of $1.34 million for fiscal year 2025, up 309.8% from fiscal year 2024, and net income of -$22.58 million. Its market capitalization was $12.02 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 9, 2026.
, a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and an immunotherapy platform.
Pluri reported $1.34 million in revenue for fiscal year 2025, up 309.8% from 326,000 ILS in fiscal year 2024.
$12.02 million as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Elite Pharmaceuticals, Inc. (ELTP), Lifecore Biomedical, Inc. (LFCR), FibroGen, Inc. (FGEN), Bio Green Med Solution, Inc. (BGMS).